CHEMICAL SYNTHESIS OF RNA VIA NOVEL STRATEGY

Information

  • Research Project
  • 6180977
  • ApplicationId
    6180977
  • Core Project Number
    R44GM056044
  • Full Project Number
    5R44GM056044-03
  • Serial Number
    56044
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1997 - 28 years ago
  • Project End Date
    5/31/2001 - 24 years ago
  • Program Officer Name
    SCHWAB, JOHN M.
  • Budget Start Date
    6/1/2000 - 25 years ago
  • Budget End Date
    5/31/2001 - 24 years ago
  • Fiscal Year
    2000
  • Support Year
    3
  • Suffix
  • Award Notice Date
    6/8/2000 - 25 years ago
Organizations

CHEMICAL SYNTHESIS OF RNA VIA NOVEL STRATEGY

DESCRIPTION: (adapted from applicant's abstract) The value of and need for routine RNA oligonucleotide synthesis has been rapidly increasing over the past decade as research reveals the extent of RNA's biological functions. Current methods enable the synthesis of RNA in acceptable yields and quality, but a high level of skill appears to be required to deliver adequate results. The focus of this NIH SBIR Phase II project is to enable a powerful new RNA synthesis technology to be readily accessible to the scientific community. The specific aims will be achieved with the following research plan: Nucleoside chemistry Optimizations of 5'- and 3'-reagents and reactions Application of synthesis methods in other labs and to modified bases Development of economical large scale phosphoramidite synthesis Oligonucleotide synthesis chemistry Standardization of reagents, modifications and methods on current instrument Testing and evaluation in collaborating independent labs Optimization of 2'-ACE chemistry on other standard synthesis instruments The successful execution of this research plan will provide the general synthesis instruments with a readily available and reliable means of synthesizing high quality RNA oligonucleotides. With a ready means of synthesizing RNA oligonucleotides, it is expected that research and health-related discoveries will follow. PROPOSED COMMERCIAL APPLICTION: NOT AVAILABLE

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    311076
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    821
  • Ed Inst. Type
  • Funding ICs
    NIGMS:311076\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    DHARMACON, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LAFAYETTE
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    800263375
  • Organization District
    UNITED STATES